News ｜ Jiksak Bioengineering

News list

IPAS program

Jiksak was selected in IPAS program by Japan patent office.

Aug 30, 2018

Announcement of New Shares through Third-Party Allotment

Jiksak Bioengineering, Inc. secures 170 Million JPY from ANRI, OHARA Pharmaceutical Co.,Ltd, Essential Pharma Co., Ltd. and MediFuture Co., Ltd. to co

Feb 21, 2018

Nakatsuji Prize

CEO Kawada received Kyoto SMI Nakatsuji Prize.

Jan 12, 2018

The report about Nerve organoid was published.

The report, “Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons” was published in Stem Cell Reports.

Aug 26, 2017

ISSCR 2017@ Boston

At International Society for Stem cell research (ISSCR) 2017, Jiksak’s technologies was presented in the poster session.

Jun 14, 2017

Start Jiksak company

Jiksak Bioengineering Inc. was established in Hongo, Tokyo.

Feb 7, 2017